A team of Collins & Jones lawyers represented the shareholders of National Enzyme Company (NEC) in the sale of the stock of NEC to Chicago-based private equity firms Prairie Capital and Skyline Global Partners.

NEC was founded in 1932 and is based in Forsythe, Missouri. The company is the leading manufacturer of specialty enzymes for the digestive health market, both in the United States and internationally.

The financial terms of the transaction were not disclosed. Josh Jones, Eric Collins and Kerry Morgan lead our team’s work on this large, complex transaction.

Firm Attorneys Eric Collins and Kerry Morgan utilize their extensive experience involving real estate purchase and sale transactions and acquisition financing to close deal

Firm attorneys Eric Collins and Kerry Morgan recently represented a client in connection with the acquisition of a retail center in southwest Missouri, which was part of a Section 1031 exchange transaction. The Firm’s attorneys represented the client as seller during...

read more